概述

  • 产品名称PD 0325901
  • 描述
    Potent MEK 1 and 2 inhibitor
  • 生物学描述Potent MEK 1 and 2 allosteric inhibitor (IC50 = 0.59 nM in vivo). Preferential binding (7-10-fold) to unphosphorylated MEK1 than pMEK1 in vitro. Induces apoptosis in malignant cells through p53, TRAIL, caspase, mitochondrial depolarisation and Bid activation. Systemically active following oral and intravenous administration.
  • 纯度> 99%

性能

    PD 0325901 (ab120639)参考文献

    This product has been referenced in:
    • Sheth PR  et al. Fully activated MEK1 exhibits compromised affinity for binding of allosteric inhibitors U0126 and PD0325901. Biochemistry 50:7964-76 (2011). Read more (PubMed: 21793567) »
    • Lunghi P  et al. Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. Blood 112:2450-62 (2008). Read more (PubMed: 18583568) »
    • Brown AP  et al. Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration. Cancer Chemother Pharmacol 59:671-9 (2007). Read more (PubMed: 16944149) »
    • Thompson N & Lyons J Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery. Curr Opin Pharmacol 5:350-6 (2005). Read more (PubMed: 15955734) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120639.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"